Leumas is on the journey to prove that India’s next-gen manufacturing capabilities can solve complex global supply chain problems with software-driven precision.
What is the news?
- Leumas, an Indian deeptech manufacturing startup, has raised $2.2 million in seed funding led by Capital 2B, with participation from Info Edge, Temasek, Capital-A, and Anicut Capital.
- The startup builds next-gen, software-driven robot factories specifically for wellness and pharma sectors, offering on-demand manufacturing and factory-as-a-service models.
- Over the past year, Leumas has co-developed manufacturing solutions with leading wellness brands and helped scale more than 120 products across India, the US, and MENA.
Why is it interesting?
- Leumas exemplifies the India-to-global manufacturing revolution we’re beginning to witness. Their cyber-physical manufacturing technology combines AI-led robotics with modular production lines, enabling continuous, traceable manufacturing with unprecedented flexibility.
- What’s compelling is their proven traction. They’ve already secured agreements with prominent pharma and food research institutions to build dedicated factory capacities using their modular factory solution.
- Their approach addresses the global manufacturing challenge of speed, compliance, and adaptability that pharma and wellness brands desperately need. This is manufacturing-as-a-service with Indian innovation solving worldwide supply chain inefficiencies.
Read more: Deeptech startup Leumas raises $2.2 million in funding to expand R&D capabilities